Logo

Kim Kelderman

Apr 24, 2018

Bio-Techne has hired Kim Kelderman as president of Diagnostics and Genomics, effective April 30. Based in California, Kelderman will lead Bio-Techne's diagnostics business, and drive and develop the company's initiatives in genomics and genomics-based diagnostics. He joins Bio-Techne from Thermo Fisher Scientific, where for the past three years he managed the platforms and content of the Genetic Sciences Division. In that position he was responsible for the instrumentation, software, consumables, and assays businesses, and brands including Applied Biosystems and legacy Affymetrix. Prior to being at Thermo Fisher, he was a segment leader at Becton Dickinson. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.